Dried tube specimens: A simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 295-300

  Parekh, Bharat S ^a   Anyanwu, Juliana ^a   Patel, Hetal ^a   Downer, Marie ^a,c   Kalou, Mireille ^a   Gichimu, Catherine ^b   Keipkerich, Bera Steven ^b   Clement, Nelly ^b   Omondi, Michael ^a   Mayer, Oren ^a   Ou, Chin Yih ^a   Nkengasong, John N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b National Public Health Laboratory Services   (Kenya)

^c CDC Cambodia ^*  (Cambodia)

Author keywords

Dried tube specimens (DTS); External quality assessment; HIV; Proficiency testing; Quality assurance

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PHOSPHATE BUFFERED SALINE; POLYSORBATE;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; KENYA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY CONTROL; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; THERMOSTABILITY;

DEVELOPING COUNTRIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; KENYA; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS; VIROLOGY;

EID: 73249119296     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.10.013     Document Type: Article

References (22)

1. Benenson A.S., Peddecord M., Hofherr L.K., Ascher M.S., Taylor R.N., and Hearn T.L. Reporting the results of human immunodeficiency virus testing. J. Am. Med. Assoc. 262 (1989) 3435-3438 (see comment)
2. Chaillet P., Zachariah R., Harries K., Rusangawa E., and Harries A.D. Dried blood spots are a useful tool for quality assurance of rapid testing in Kigali, Rwanda. Trans. R. Soc. Trop. Med. Hyg. 103 (2009) 634-637
3. Chalermchan W., Pitak S., and Sungkawasee S. Evaluation of Thailand national external quality assessment on HIV testing. Int. J. Health Care Qual. Assur. 20 (2007) 130-140
4. Francis D.P., Peddecord K.M., Ferran K.L., Benenson A.S., Hofherr L.K., Garfein R.S., Schalla W.O., and Taylor R.N. Use of a modified nominal group process for improving laboratory performance in human immunodeficiency virus type 1 antibody testing. Reaching consensus on three questions concerning HIV-1 testing. Clin. Lab. Manage. Rev. 6 (1992) 537-538
5. Goguel A.F. HBV and HIV serological markers: the National External Quality Assessment Scheme in France. Ann. Ist. Super. Sanita 27 (1991) 511-515
6. Hannon W.H., Lewis D.S., Jones W.K., and Powell M.K. A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens. Infect. Control Hosp. Epidemiol. 10 (1989) 8-13
7. Hofherr L.K., Peddecord K.M., Benenson A.S., Garfein R.S., Francis D.P., Ferran K.L., and Taylor R.N. Methods for a model blind proficiency testing system. Clin. Lab. Sci. 5 (1992) 160-164
8. Jackson J.B., Drew J., Lin H.J., Otto P., Bremer J.W., Hollinger F.B., and Wolinsky S.M. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J. Clin. Microbiol. 31 (1993) 3123-3128
9. Jereni B.H., and Muula A.S. Availability of supplies and motivations for accessing voluntary HIV counseling and testing services in Blantyre, Malawi. BMC Health Serv. Res. 8 (2008) 17
10. Kudlac J., Hanan S., and McKee G.L. Development of quality control procedures for the human immunodeficiency virus type 1 antibody enzyme-linked immunosorbent assay. J. Clin. Microbiol. 27 (1989) 1303-1306
11. Learmonth K.M., McPhee D.A., Jardine D.K., Walker S.K., Aye T.T., and Dax E.M. Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. J. Clin. Microbiol. 46 (2008) 1692-1697
12. Parekh B.S., Kennedy M.S., Dobbs T., Pau C.P., Byers R., Green T., Hu D.J., Vanichseni S., Young N.L., Choopanya K., Mastro T.D., and McDougal J.S. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retroviruses 18 (2002) 295-307
13. Peddecord K.M., Benenson A.S., Hofherr L.K., Francis D.P., Garfein R.S., Ferran K.L., Taylor R.N., Schalla W.O., and Ascher M.S. Analytic results of HIV-1 testing using blind proficiency testing. Clin. Lab. Sci. 5 (1992) 165-171
14. Plate D.K., and Rapid HIV Test Evaluation Working Group. Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res. Hum. Retroviruses 23 (2007) 1491-1498
15. Polesky H.F., and Hanson M.R. Human immunodeficiency virus type 1 proficiency testing. The American Association of Blood Banks/College of American Pathologists Program. Arch. Pathol. Lab. Med. 114 (1990) 268-271
16. Reichelderfer P.S., and Jackson J.B. Quality assurance and use of PCR in clinical trials. PCR Methods Appl. 4 (1994) S141-S149
17. Rickman W.J., Monical C., and Waxdal M.J. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing. Ann. N.Y. Acad. Sci. 677 (1993) 53-58
18. Schalla W.O., Hearn T.L., Taylor R.N., Eavenson E., Valdiserri R.O., and Essien J.D. CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep. 105 (1990) 167-171
19. Schwartz J.S., Dans P.E., and Kinosian B.P. Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better. J. Am. Med. Assoc. 259 (1988) 2574-2579
20. Schweiger B., Pauli G., Zeichhardt H., and Kucherer C. A multicentre quality assessment study to monitor the performance of HIV-1 PCR. J. Virol. Methods 67 (1997) 45-55
21. Wang J.S., Kee M.K., Suh S.D., Shin H.S., Kim H.S., and Kim S.S. Post-evaluation of rapid HIV kits in the Korean market by an anti-HIV EQAS panel. J. Virol. Methods 141 (2007) 141-145
22. Yen-Lieberman B., Brambilla D., Jackson B., Bremer J., Coombs R., Cronin M., Herman S., Katzenstein D., Leung S., Lin H.J., Palumbo P., Rasheed S., Todd J., Vahey M., and Reichelderfer P. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34 (1996) 2695-2701